Save time and get answers to complex questions with AI chat
When genetic tenofovir alafenamide be available in us?How many years does kadcyla's market exclusivity last?Are there income restrictions for lipitor's patient program?Abbvie humira patent cliff navigation success?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for Zeposia
Zeposia (ozanimod) is made by Bristol Myers Squibb (BMS).
Bristol Myers Squibb markets Zeposia in its key markets, with the underlying drug substance being developed and commercialized by BMS.
For manufacturer-linked commercial details like patents and exclusivity status, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Often, a brand’s sponsor/marketer and the drug’s manufacturing partners can differ. For Zeposia, the brand is associated with Bristol Myers Squibb, while different contract manufacturing sites may be used for production under BMS’s oversight.
Zeposia (ozanimod) is used for relapsing forms of multiple sclerosis and for ulcerative colitis. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Zeposia :